Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Volker V Vetter"'
Publikováno v:
Indian Journal of Public Health, Vol 63, Iss 3, Pp 243-250 (2019)
Rotavirus is a leading cause of severe pediatric diarrhea worldwide, with about 199,000 childhood deaths in 2015, of which 90% in low-income countries. India alone accounts for 22% of the global rotavirus gastroenteritis (RVGE)-related deaths among c
Externí odkaz:
https://doaj.org/article/ca7c143be1f7406bbf86d76bc2083e61
Publikováno v:
Indian Journal of Public Health, Vol 63, Iss 3, Pp 243-250 (2019)
Rotavirus is a leading cause of severe pediatric diarrhea worldwide, with about 199,000 childhood deaths in 2015, of which 90% in low-income countries. India alone accounts for 22% of the global rotavirus gastroenteritis (RVGE)-related deaths among c
Autor:
Oh KB; Vaccines R&D, GSK, Wavre, Belgium., Doherty TM; Global Medical Affairs Adult Immunization, GSK, Brondby, Denmark., Vetter V; Vaccines R&D Global Medical Affairs, GSK, Munich, Germany., Bonanni P; Department of Health Sciences, University of Florence, Florence, Italy.
Publikováno v:
Expert review of vaccines [Expert Rev Vaccines] 2023 Jan-Dec; Vol. 22 (1), pp. 528-529.
Autor:
van der Zee C; Office of the Chief Medical Officer, GSK, Wavre, Belgium., Delpire V; Words & Science, Brussels, Belgium., Vetter V; Global Medical Affairs, GSK, Wavre, Belgium., Poplazarova T; Office of the Chief Medical Officer, GSK, Wavre, Belgium.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 2021765. Date of Electronic Publication: 2022 Feb 03.
Autor:
Vetter V; Medical Affairs Department, GSK, Wavre, Belgium.; Vaccines R&D - Technical R&D, GSK, Wavre, Belgium., Gardner RC; Medical Affairs Department, GSK, Wavre, Belgium.; Vaccines R&D - Technical R&D, GSK, Wavre, Belgium., Debrus S; Medical Affairs Department, GSK, Wavre, Belgium.; Vaccines R&D - Technical R&D, GSK, Wavre, Belgium., Benninghoff B; Medical Affairs Department, GSK, Wavre, Belgium.; Vaccines R&D - Technical R&D, GSK, Wavre, Belgium., Pereira P; Medical Affairs Department, GSK, Wavre, Belgium.; Vaccines R&D - Technical R&D, GSK, Wavre, Belgium.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 1870395. Date of Electronic Publication: 2021 Feb 19.
Autor:
Izurieta P; GSK, Wavre, Belgium., Scherbakov M; GSK, Moscow, Russian Federation., Nieto Guevara J; GSK, Panama City, Panama., Vetter V; GSK, Wavre, Belgium., Soumahoro L; GSK, Wavre, Belgium.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 2013693. Date of Electronic Publication: 2022 Jan 12.
Autor:
Oh KB; GSK, Wavre, Belgium., Doherty TM; GSK, Brondby, Denmark., Vetter V; GSK, Munich, Germany., Bonanni P; Department of Health Sciences, University of Florence, Florence, Italy.
Publikováno v:
Expert review of vaccines [Expert Rev Vaccines] 2022 Nov; Vol. 21 (11), pp. 1541-1553. Date of Electronic Publication: 2022 Sep 05.
Autor:
Kauffmann F; GSK, Avenue Fleming 20, 1300 Wavre, Belgium., Heffernan C; NHS England (London Region), 1st Floor, Wellington House, 133-155 Waterloo Road, London, SE16UG, UK., Meurice F; GSK, Avenue Fleming 20, 1300 Wavre, Belgium.; Biomedical Sciences Department, Faculty of Medicine, University of Namur (UNamur), Rue de Bruxelles 61, 5000 Namur, Belgium., Ota MOC; GSK, Avenue Fleming 20, 1300 Wavre, Belgium., Vetter V; GSK, Avenue Fleming 20, 1300 Wavre, Belgium., Casabona G; GSK, Avenue Fleming 20, 1300 Wavre, Belgium.
Publikováno v:
Expert review of vaccines [Expert Rev Vaccines] 2021 Jul; Vol. 20 (7), pp. 811-826. Date of Electronic Publication: 2021 Jun 07.
Autor:
Izurieta P; GlaxoSmithKline, 1300 Wavre, Belgium. Electronic address: patricia.s.izurieta@gsk.com., Scherbakov M; GlaxoSmithKline, Moscow, Russia., Vetter V; GlaxoSmithKline, 1300 Wavre, Belgium.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Feb; Vol. 21 (2), pp. 169-170.
Autor:
Willame C; GSK Vaccines , Wavre, Belgium., Cheuvart B; GSK Vaccines , Wavre, Belgium., Aris E; GSK Vaccines , Wavre, Belgium., Vetter V; GSK Vaccines , Wavre, Belgium., Cohet C; GSK Vaccines , Wavre, Belgium.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Jan 02; Vol. 17 (1), pp. 269-277. Date of Electronic Publication: 2020 Jul 01.